TRANSCODE THERAPEUTICS, INC.
  • Home
    • Mission
    • Clinical Trials
  • About
    • Metastatic Disease
    • Lead Candidate
    • Science
    • Pipeline >
      • Delivery Platform
      • Other Products
    • Leadership
  • Publications
  • Investors
  • Careers
    • Partnering

Leadership

Leadership

TransCode's senior leadership team combines decades of oncology drug discovery and development expertise,  to add both scientific insight and valuable strategic perspective to address cancer and create a sustainable commercialization product pipeline. 

Executive Team

Picture
R. ​Michael Dudley
Founder, President & CEO
Picture
Zdravka Medarova, PhD
Founder/Chief Technology Officer
Picture
Tom Fitzgerald, MBA
CFO, VP of Administration
Picture
Susan Duggan, RN, MBA
Sr. VP of Operations
Picture
Dustan Bonnin, CVA, MBA
VP of Strategy & Innovation
Picture
Peter Liu, PhD
         VP Drug Discovery            Chief Scientist
Picture
Alan Freidman
​VP Investor & Client Relations
Picture
Subrata Ghosh, PhD
​Principal Scientist
Picture
Ram Bhat, PhD
​Sr. Director CMC
In Memoriam 1961-2023

Board of Directors

Picture
Philippe Calais, PhD
​Board Chair
Picture
Magda Marquet, PhD
​Director
Picture
Erik Manting, PhD
​Director
Picture
Michael Dudley, President, CEO and Director
Picture
Tom Fitzgerald
CFO,
 Director

Advisory Board

Picture
Anna Moore, PhD
​Founder
Picture
Keith Flaherty, MD
Picture
Raghu Kalluri, MD, PhD
Picture
George Calin, MD, PhD
Picture
Dejan Juric, MD

Picture
Dmitry Samarsky
​PhD
Picture
G. Susan Srivatsa
​PhD
Picture
Raul Mostoslavsky
​MD, PhD
Picture
Lubomir Nechev
​PhD
Picture
Frank J.Slack
​PhD

Picture
Mehmet Yigit
​PhD
Picture
Betsabeh Madani Hermann
​MBA​, MENG
Picture
Jerome Lewis
​PhD, MBA
Picture
John Henneman III
​JD
Picture
Oliver Steinbach
​PhD
TTX is an investigational platform encompassing therapeutic candidates (including TTX-MC138) and diagnostics which remain in development. Their safety and efficacy have not yet been evaluated by the FDA or any other regulatory agency.

Home

​MISSION
​CLINICAL TRIALS

About

​METASTATIC DISEASE
TTX-MC138
​SCIENCE
​PIPELINE
​DELIVERY PLATFORM
​OTHER PRODUCTS
​LEADERSHIP


Publications

​PUBLICATIONS

Careers

​​​​​CAREERS
​
PARTNERING




Contact/Support

CONTACT
​TERMS OF USE
PRIVACY POLICY
FCOI Policy
​
© TRANSCODE THERAPEUTICS, INC. 2023.​ ALL RIGHTS RESERVED.
  • Home
    • Mission
    • Clinical Trials
  • About
    • Metastatic Disease
    • Lead Candidate
    • Science
    • Pipeline >
      • Delivery Platform
      • Other Products
    • Leadership
  • Publications
  • Investors
  • Careers
    • Partnering